Get the Stockscreener App
2.865
3.05%
0.085
Cronos Group Inc stock is traded at $2.865, with a volume of 770.61K.
It is up +3.05% in the last 24 hours and up +1.59% over the past month.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
See More
Previous Close:
$2.78
Open:
$2.78
24h Volume:
770.61K
Relative Volume:
0.53
Market Cap:
$1.07B
Revenue:
$159.54M
Net Income/Loss:
$5.06M
P/E Ratio:
-651.14
EPS:
-0.0044
Net Cash Flow:
$26.19M
1W Performance:
+5.72%
1M Performance:
+1.59%
6M Performance:
+8.93%
1Y Performance:
+49.21%
1-Day Range:
$2.78
$2.895
1-Week Range:
$2.675
$2.895
52-Week Range:
$1.91
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
2.865 | 1.05B | 159.54M | 5.06M | 26.19M | -0.0044 |
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 50.27B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.385 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 38.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
73.97 | 31.90B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
543.00 | 23.03B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Cronos Group Inc.'s Equity Buyback announced on May 8, 2025, has expired. - marketscreener.com
Cronos appoints ATB Cormark as new broker for Canadian share repurchases under its buyback program - Pluang
Cronos Group changes broker for share repurchase program - Investing.com
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada - GlobeNewswire
Cronos Group (CRON) adds director Darren Chester Broughton as reporting insider on Form 3 - Stock Titan
TSX Penny Stocks To Watch In June 2026 - simplywall.st
CRONCronos Group Inc Volatility & Greeks - Finviz
Cronos Group Inc. stock rises Monday, still underperforms market - MarketWatch
Price to earnings forward of Cronos Group Inc – TSX:CRON - TradingView
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
CRON strengthens global footprint: Is the cannabis stock worth buying? - MSN
CRON Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (TSX:CRON) - TradingView
Cronos Group Inc Actuals & Estimates (FWB:7CI) - TradingView
7CI Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (NEO:CRON) - TradingView
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm
Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group Inc (CRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cronos Group shareholders approve board slate and auditor at annual meeting By Investing.com - Investing.com Australia
Form 8K CRONOS GROUP INC. For: 22 June By Investing.com - Investing.com India
Cronos Group Inc. (CRON) Announces 2026 Annual Meeting Results and Key SEC Filing Details - Minichart
Cronos Group shareholders approve board slate and auditor at annual meeting - Investing.com
Cronos Group shareholders re-elect directors and approve executive pay at 2026 annual meeting - Pluang
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Cronos Group (NASDAQ: CRON) holders back pay and auditor at 2026 meeting - Stock Titan
Cronos Group shareholders back board, pay vote and auditor - Stock Titan
Cronos Group StockAnalyst views and long-term cannabis strategy - AD HOC NEWS
Why Is Cronos Group Inc. (TSX:CRON) Rising After Buyback in S&P/TSX Composite Index? - Kalkine Media
Should Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors? - Yahoo Finance
Cronos Group Inc (CRON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cronos Group Inc. stock rises Thursday, still underperforms market - MarketWatch
CRON: All agenda items, including director elections and auditor appointment, were approved without dissent - TradingView
Cronos Extends Share Repurchase Program to Toronto Stock Exchange - Moomoo
Cronos Group Inc (CRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cronos Group Inc (CRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cronos Group Inc (CRON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cronos Group Inc (CRON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cronos Group Inc (CRON) Institutional Confidence - TradingKey
Cronos Group Inc (CRON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cronos Group Inc (CRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cronos Group files to expand share buyback to TSX By Investing.com - Investing.com India
Cronos Group Inc. stock outperforms market despite losses on the day - MarketWatch
Cronos Group files to expand share buyback to TSX - Investing.com
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange - GlobeNewswire
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):